Company intelligence / Profile preview

Mexican Pharmacy

Ownership: Private
Development stage: Other

Overview

Mexican Pharmacy ("Mexglobal") is an active pharmaceutical and biotechnology market access partner specializing in bringing innovative therapies to the USA and Mexico. The company collaborates with leading global pharma/biotech firms to distribute high-tech pharmaceuticals—especially in oncology, rare diseases, neurology, cardiology, gynecology—and provides expertise in regulatory affairs, pricing/reimbursement strategy, medical education, logistics for sensitive products like biologics/oncolytics[1].

Modalities: Small moleculeBiologicMonoclonal antibodyPlasma-derived therapy
Industry: Consulting

Partnerships

AlmirallHikma PharmaceuticalsGrifolsBiotoscana/Knight TherapeuticsItalfarmacoMedac PharmaRecordati

Beyond the preview

Go deeper on Mexican Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mexican Pharmacy.

Explore the full profile